Following the sale of Kos Pharmaceuticals, Inc. to Abbott Laboratories in late 2006, Vatera Capital LLC was founded in early 2007 by Michael Jaharis and associates. Vatera considers investments in biopharmaceutical companies across stages, sub-sectors, and capital structures.

The Vatera team brings to bear a unique set of experiences, skills, and perspectives that differentiate us from other healthcare-focused venture capital and private equity firms:

Woman Examining Chest X-Ray

Track Record of Success

  • Through the team's experience with Key Pharmaceuticals and Kos Pharmaceuticals, we have the proven ability to establish and grow market-leading specialty pharmaceutical companies. Vatera seeks to add value to each of the companies we invest in by applying the insights gained through our deep experience, and we take an active role in the management of each of our portfolio companies.

    You can learn more about the team's experience at Key Pharmaceuticals and Kos Pharmaceuticals by clicking on either company's logo below:
Key Pharmaceuticals logo Kos Pharmaceuticals logo

Network

  • We have an extensive and long-standing network in the healthcare industry due to our experience and high-level contacts in many large pharmaceutical companies, start-up biotech companies, and academia.
  • Our Advisory Board is comprised of industry veterans, each with deep experience and tremendous insight into the trends that drive innovation in our industry.

Investment Philosophy

  • We believe value is created by building sustainable companies for the long-term that are not driven by short-term decision-making.
  • Success is achieved by creating a true partnership with our portfolio companies' management teams based on trust, transparency, integrity, and honesty.
  • We target investments in portfolio companies that believe in putting patients' interests first by developing innovative products for unmet and underserved medical needs.